Bohui Innovation: Holding subsidiary jointly obtains notice of approval for drug clinical trials.

Bohui Innovation Announcement: A joint application by Bohui Biopharmaceutical Co., Ltd., a holding subsidiary of Bohui Innovation, and Beijing Baihui Biotechnology Co., Ltd. for the freeze-dried combination vaccine of type B influenza and hemophilic bacteria has been approved by the National Medical Products Administration, issuing the "Drug Clinical Trial Approval Notice" to allow for clinical trials.